- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Ceregene
Total 1119 results
-
Johns Hopkins UniversityCelgene CorporationCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Caregen Co. Ltd.CBCC Global ResearchNot yet recruitingAge-related Wet Macular DegenerationUnited States
-
Josep Carreras Leukaemia Research InstituteCelgeneRecruitingMyelodysplastic SyndromesSpain
-
Massachusetts General HospitalCelgene; OncoPep, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingFollicular Lymphoma | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell Lymphoma | Mantle-cell LymphomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, NonhodgkinUnited States
-
Columbia UniversityGenentech, Inc.; Celgene CorporationCompletedCarcinoma, Non-Small-Cell LungUnited States
-
University of NebraskaGlaxoSmithKline; Celgene CorporationCompletedNon-Hodgkin's LymphomaUnited States
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
AIO-Studien-gGmbHCelgene; ClinAssess GmbHCompletedResectable Pancreatic Cancer | Ductal Adenocarcinoma of the PancreasGermany
-
Oslo University HospitalCelgene Corporation; AmgenActive, not recruitingLichen Planus of Vulva | Female Genital DiseaseNorway
-
PETHEMA FoundationCelgene Corporation; Array BioPharmaCompleted
-
University of BirminghamCelgene; Amgen; BloodwiseCompletedPeripheral T Cell LymphomaUnited Kingdom
-
Juno Therapeutics, a Subsidiary of CelgeneAvailableLymphoma, Large B-Cell, Diffuse
-
SCRI Development Innovations, LLCCelgene CorporationCompletedBreast CancerUnited States
-
Heinrich-Heine University, DuesseldorfCelgene CorporationCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicGermany
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemiaUnited States
-
Dana-Farber Cancer InstituteCelgene CorporationTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of Southern CaliforniaCelgene CorporationTerminatedCancer | Venous ThromboembolismUnited States
-
University of Kansas Medical CenterCelgeneTerminatedRenal Cell CarcinomaUnited States
-
Shams ShakilCelgeneCompletedLymphoma | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Sunnybrook Health Sciences CentreCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
French Innovative Leukemia OrganisationCelgene CorporationCompletedAcute Myeloid LeukemiaFrance
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedMelanoma | Liver MetastasisUnited States
-
Seoul St. Mary's HospitalCelgene CorporationUnknownMyelodysplastic SyndromeKorea, Republic of
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Duke UniversityGenentech, Inc.; Celgene CorporationCompletedBreast CancerUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedGraft-versus-Host DiseaseUnited States
-
SCRI Development Innovations, LLCCelgene CorporationCompletedMetastatic Pancreatic CancerUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedPain | Advanced CancerUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Groupe Francophone des MyelodysplasiesCelgene CorporationTerminatedMyelodysplastic Syndromes | Leukemia, Myelocytic, AcuteFrance
-
SCRI Development Innovations, LLCCelgene CorporationCompletedMetastatic Breast CancerUnited States
-
SCRI Development Innovations, LLCCelgene CorporationTerminated
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
CelgeneThe Lymphoma Academic Research OrganisationActive, not recruitingFollicular LymphomaUnited States, Japan
-
The Lymphoma Academic Research OrganisationCelgeneActive, not recruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
EyeGene Inc.Novotech (Australia) Pty LimitedActive, not recruiting
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingMultiple MyelomaUnited States
-
University Health Network, TorontoAbbVie; CelgeneTerminatedAcute Myeloid Leukemia | Relapsed Cancer | Refractory Cancer | IDH2 Gene MutationCanada
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruiting
-
University of Alabama at BirminghamCelgeneCompletedPsoriasis | Psoriasis Vulgaris | Psoriatic NailUnited States
-
University of LeedsCelgene; Myeloma UKActive, not recruitingMultiple MyelomaUnited Kingdom
-
Presage BiosciencesBristol-Myers Squibb; CelgeneTerminated
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Washington University School of MedicineCelgeneCompletedLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralUnited States
-
Washington University School of MedicineCelgeneCompletedHead and Neck NeoplasmsUnited States